Your session is about to expire
← Back to Search
Olanzapine for Chemotherapy-Induced Nausea and Vomiting in Gynecologic Cancer
Study Summary
This trial will compare the effectiveness of olanzapine versus neurokinin-1 receptor antagonists in preventing chemotherapy-induced nausea and vomiting in gynecologic cancer patients receiving outpatient chemotherapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2008 Phase 4 trial • 25 Patients • NCT00001656Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Can you detail the dangers associated with Olanzapine?
"Because Olanzapine has gone through multiple rounds of testing and has shown to be effective in some cases, we have given it a safety rating of 3."
Are individuals of all ages being considered for participation in this experiment?
"The age limit for patients recruited for this clinical trial is 89 years old. All participants must also be of legal age, meaning that they are at least 18 years old."
Out of all the patients who could potentially take part in this study, how many have agreed to do so?
"Yes, this is an ongoing study that is still recruiting participants. According to the information on clinicaltrials.gov, the trial was posted on December 28th 2020 and most recently edited on January 6th 2022. The research team is looking for 170 individuals total, across 1 location."
For what reasons is Olanzapine typically prescribed?
"Olanzapine is typically used to treat ophthalmia and sympathetic, but it can also be given as a branch retinal vein occlusion, macular edema, or communicable disease intervention."
Which individuals does this clinical trial seek as participants?
"Women who have been diagnosed with gynecologic cancers and are between the ages of 18-89 may be eligible for this clinical trial. Up to 170 patients are needed in total."
Share this study with friends
Copy Link
Messenger